There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Travere Therapeutics (TVTX) and Glaukos (GKOS) with bullish sentiments. According to TipRanks.com, Rama ...

View U.S. Physical Therapy, Inc. USPH stock quote prices, financial information, real-time forecasts, and company news from CNN.

Travere Therapeutics Inc, a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease, announced ...

Vera Therapeutics Inc. research and ratings by Barron's. View VERA revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Patent Application No. 19/253,088, titled ...

Years of legal battles have culminated in a decisive judgment against a well-known Toronto plastic surgeon, Dr. Martin Jugenburg. The ruling follows a comprehensive five-week common issues trial that ...

The United States market has shown robust performance with a 2.5% increase over the last week and a remarkable 26% rise in the past year, while earnings are projected to grow by 17% annually. In this ...

The FDA has delayed a decision on the approval of AstraZeneca’s camizestrant, deferring its ruling to review analyses filed ...

Travere Therapeutics is Thursday's IBD Stock Of The Day. Shares are lingering around a buy zone after gapping up on an FDA approval ...

Kirk Campbell, MD, discusses why FSGS is traditionally difficult to treat, the significance of the sparsentan approval, and future access needs. He discussed the longstanding challenges of treating ...

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.